Kerynn Morss is still looking for a donor match for her son Broeden Sabin, who was diagnosed with acute myeloid leukemia in December 2025 ...
New research into acute myeloid leukemia could change future treatment approaches.
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...
Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an aggressive blood cancer affecting the bone ...
While not every patient with AML develops skin involvement, it can be one of the earliest visible signs that something systemic is occurring.
Blackstone Life Sciences ("BXLS") today announced a research and development funding agreement to advance the clinical ...
Reducing Uncertainty in the Care and Treatment of Blood Cancer ST. LOUIS, MO, UNITED STATES, February 23, 2026 ...
Biphenotypic leukemia is a mixed type of leukemia that originates in both lymphoid and myeloid cells. It typically has a poorer outlook than other acute leukemias. A stem cell transplant may improve ...